Skip to content
Search

Latest Stories

NHS gets £6.6bn in additional funding for Covid-19 response and recovery

The government today (March 18) has announced a new funding boost of £7bn for health and social care services, to support the next phase of the NHS's response to the Covid-19 pandemic.

The NHS will receive £6.6bn in additional funding over the next six months to support the continuation of the NHS response to Covid-19, and the recovery of elective services as hospitalisations continue to fall, health secretary Matt Hancock has announced.


The funding will support the hospital discharge programme, primary care costs, infection control measures and long Covid services.

It will also ensure that the NHS can continue to provide the mental health and occupational health support services it has put in place for nurses, paramedics, therapists, pharmacists, and other staff working on the frontline during the pandemic.

The latest funding brings the total package of additional support given to the health services for Covid-19 to £92bn, with £63bn this year and £29bn for the next.

Hancock said: “We’ve backed the NHS at every point in this pandemic, so they can treat patients, stay safe and save lives.

“We’re backing them again today with a further £6.6 billion of funding for the first half of this financial year, including £594 million towards safe hospital discharge.

“I can announce £341 million to support adult social care with the costs of infection prevention control and testing that will make sure visits are safe for everyone.

“We will also be extending enhanced discharge arrangements for mental health patients.”

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less